Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Change in Cash (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Change in Cash for 3 consecutive years, with $65.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Cash rose 1046.28% to $65.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $128.4 million, a 1953.35% increase, with the full-year FY2025 number at $128.4 million, up 1953.35% from a year prior.
  • Change in Cash was $65.2 million for Q4 2025 at Nuvation Bio, up from -$149.1 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $200.0 million in Q2 2025 to a low of -$149.1 million in Q3 2025.
  • A 3-year average of $5.2 million and a median of $2.7 million in 2024 define the central range for Change in Cash.
  • Biggest YoY gain for Change in Cash was 88985.78% in 2025; the steepest drop was 3408.43% in 2025.
  • Nuvation Bio's Change in Cash stood at $18.3 million in 2023, then crashed by 68.85% to $5.7 million in 2024, then surged by 1046.28% to $65.2 million in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Change in Cash are $65.2 million (Q4 2025), -$149.1 million (Q3 2025), and $200.0 million (Q2 2025).